FY26 126746 - B560 emergency generator

Active Awarded Last action

Contract number
75N91026F00004
Awardee
Awarding agency
Obligated
$868,976

Award facts

Opportunity
  • NCINCIFOSO260017 Solicitation number
Contract value 100% obligated
$868,976.00 Current and potential, with all options
Completion date 29% complete
Current and potential, with all options
NAICS code
541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
PSC
AN12 Health R&D Services; Health Care Services; Applied Research
Set-aside
No set-aside
Competition
Full and Open Competition Negotiated Proposal / Quote
Pricing
Cost Plus Fixed Fee
Place of performance
Frederick, MD 21702, USA
Legislative mandates

Award details come from SAM.gov/FPDS.

About this award

The National Cancer Institute (NCI) awarded a delivery order valued at approximately $869K to Leidos Biomedical Research Inc. for an emergency generator (B560) at the agency's Frederick, Maryland facility. The contract, awarded on April 14, 2026, is structured as a cost-plus-fixed-fee delivery order with an ultimate completion date of February 7, 2028. No set-aside designation was applied to this award. As a Federally Funded Research and Development Center (FFRDC) contractor, Leidos Biomedical Research Inc. serves as the primary support services provider for NCI and the broader National Institutes of Health, delivering comprehensive biomedical research and facilities infrastructure support across the Frederick National Laboratory for Cancer Research campus.

Leidos Biomedical Research Inc. is a subsidiary of Leidos Holdings, Inc., a large prime federal contractor headquartered in Reston, Virginia, with extensive experience managing complex government facilities and infrastructure projects. This emergency generator procurement represents a critical facilities infrastructure improvement supporting the continuity of biomedical research operations at NCI's Frederick location, where the company provides ongoing laboratory management, research support, and facility services. The emergency power system enhancement aligns with the company's broader role in maintaining and upgrading the scientific and operational infrastructure necessary to support the agency's cancer research mission and the collaborative research initiatives conducted at the Frederick National Laboratory.

Quick answers

Who was awarded contract 75N91026F00004?

75N91026F00004 was awarded to Leidos Biomedical Research Inc. by National Cancer Institute (National Institutes of Health) on April 14, 2026.

How much is contract 75N91026F00004 worth?

The government has obligated $868,976 on 75N91026F00004.

Is contract 75N91026F00004 an order under another contract?

Yes. 75N91026F00004 is a delivery order under 75N91019D00024, an indefinite delivery contract.

Was contract 75N91026F00004 competed?

The extent of competition for 75N91026F00004 was full and open competition.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award